Cargando…
The benefit of bevacizumab therapy in patients with refractory vasogenic edema caused by brain metastasis from lung and colon cancers
OBJECTIVE: This retrospective study investigated the efficacy of bevacizumab in refractory brain edema caused by brain metastasis from lung cancer and colon cancer. METHODS: A total of 72 patients with refractory brain edema were divided into the lung cancer and colon cancer groups according to thei...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559828/ https://www.ncbi.nlm.nih.gov/pubmed/36249059 http://dx.doi.org/10.3389/fonc.2022.838670 |